Pharmafile Logo
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • - PMLiVE
  • Communiqué 53 Cover Image

Future Science Group

We are an expanding group of independent publishing companies active in the field of scientific information and endeavor, currently composed of Expert Reviews, Future Medicine and Future Science. As a leading provider of products and services for the medical, scientific and business communities, we save customers time and money by presenting the most important scientific breakthroughs in an accessible and evaluated format, while at the same time providing the scientific community with unique vehicles for disseminating forward-thinking research information and data.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Springer Nature

Springer Nature

Did you know that we publish over 3,000 journals, and that over 1,000 of those are clinical science journals? Promote your approved branded drugs and medical devices to our audience…

View Profile

Advertising, Medical communications, Publishers

Streaming Well - Video For Healthcare

Streaming Well

Streaming Well is a healthcare-focused, award-winning video production company which operates in the US and Europe. We create engaging visual stories and interactive experiences that connect with people.

View Profile

Advertising, Branding, Clinical Research, Conference/meetings/events, Creative and design, Digital communications, Medical communications, Medical education, Publishers, Translation services

- PMLiVE

Wisepress

Wisepress is a medical bookseller promoting and selling books worldwide, both online and via the 200 European medical conferences that we attend each year.

View Profile

Medical communications, Medical education, Publishers

Company Details

Future Science Group
Unitec House, 1 Albert Place, Finchley, London, N3 1QB, United Kingdom
+44 (0)20 8371 4051
Contact Future Science Group
Website

 Latest Content from PMHub 

Focus on multiple myeloma treatment: Witnessing a transformation

White Papers and Resources | March 15, 2016 | Blue Latitude Health

Consultant David Cooney of Blue Latitude Health will take you through how that transformation has happened, and where the treatment of multiple myeloma is heading.

The ROI of user experience in pharma and healthcare: How to engage your customers

White Papers and Resources | March 14, 2016 | Blue Latitude Health

In this article, Head of Customer Experience Elisa del Galdo of Blue Latitude Health breaks down how to understand the return on investment of user experience in pharma and healthcare.

Why health psychology should inform pharma strategy

Press Releases | March 10, 2016 | Lucid Group Communications Limited

In the March 2016 edition of PME, Ella Nuttall (Health Psychology Specialist at Lucid Group) discusses why pharma should look to health psychology and adopt a behaviour-change strategy to inform...

Pegasus shortlisted for four PM Society Digital Media Awards 2016

Press Releases | March 8, 2016 | Inizio

Pegasus, the UK’s leading independent health communications consultancy, has had recognition of its work in digital media with shortlistings for four awards at the PM Society Digital Media Awards 2016...

Why does content need a strategy?

White Papers and Resources | March 7, 2016 | Blue Latitude Health

Not all organisations are in a position to look at maturity – for some, there’s still a pressing question that needs answering: Why does content need a strategy? Content Marketing...

Seven ways to make centrally-produced content fit affiliates’ needs

White Papers and Resources | March 3, 2016 | Anthill Agency

It’s common to encounter some degree of local resistance to centrally-produced sales materials. But don’t despair. A few simple content strategies can make a huge difference. Here are seven ideas...

Lucid Group celebrate 9 years of changing patients’ lives

Press Releases | March 3, 2016 | Lucid Group Communications Limited

Lucid Group had fun and games celebrating their nine year anniversary in their London offices last week. Lucid has grown from the two founders working out of a basement to...

Infographic: HCV EU

White Papers and Resources | March 3, 2016 | Inizio

Research findings from our Therapy HCV study shows that 28% of HCV patients in the EU are infected by sharing needles or drug equipment.Our latest market snapshot offers an introduction...

Taiwan: Exploring the Healthcare Opportunity in this Singular “Hybrid” Market

White Papers and Resources | March 3, 2016 | Inizio

Published in eyeforpharma February 2016 by Rachel Howard

Gaining deeper insights within a hard to reach audience

White Papers and Resources | March 3, 2016 | Inizio

Often a short research study isn’t sufficient to get the level of insights and understanding that you require, especially when working with a hard to reach target audience.It can also...